Clinical Trial Highlights

• Tofacitinib in Patients with Active RA with an Inadequate Response to Tumor Necrosis Factor Inhibitors
• Long-Term Safety and Efficacy of Denosumab in Postmenopausal Osteoporosis
• Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis
• Reduced CV Risk with Use of MTX and TNF-α Inhibitors in Patients with RA
• TENDER Trial 2-Year Outcomes Show Long-Term Benefits of Tocilizumab in sJIA
• Long-Term Results of the RAVE Trial
• JAK2 Reduces Basal Synthesis of Collagen in SSc Fibroblasts
• The Intensive Diet and Exercise for Arthritis Trial: 18-Month Clinical Outcomes
• Genome-Wide Analysis of Imputed Genotypes Identifies CCR1/CCR3 as Novel Risk Locus in Behçet Disease
• PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity